Evans' syndrome following vaccination with ChAdOx1 nCoV-19 in a patient with new-onset localized scleroderma.
COVID-19 vaccination
Evans’
SARSCoV- 2 vaccine
autoimmune hemolytic anemia
immune thrombocytopenic purpura
morphea
scleroderma
syndrome
Journal
Dermatology reports
ISSN: 2036-7392
Titre abrégé: Dermatol Reports
Pays: Italy
ID NLM: 101566470
Informations de publication
Date de publication:
21 Nov 2022
21 Nov 2022
Historique:
received:
07
01
2022
accepted:
20
01
2022
entrez:
9
12
2022
pubmed:
10
12
2022
medline:
10
12
2022
Statut:
epublish
Résumé
Growing evidence suggests that COVID-19 vaccines can induce hematological conditions. Here, we report a case of Evans' syndrome, a combination of immune thrombocytopenic purpura and autoimmune hemolytic anemia following administration of the ChAdOx1 nCoV-19 vaccine. The present case further supports the notion that COVID-19 vaccines can trigger in rare cases severe persistent autoimmune-mediated hematological conditions which may predominantly occur in patients with underlying autoimmune conditions.
Identifiants
pubmed: 36483231
doi: 10.4081/dr.2022.9470
pmc: PMC9724721
doi:
Types de publication
Journal Article
Langues
eng
Pagination
9470Informations de copyright
©Copyright: the Author(s).
Déclaration de conflit d'intérêts
Conflict of interest: The authors declare no conflicts of interest.
Références
J Autoimmun. 2021 Jul;121:102662
pubmed: 34051613
J Thromb Haemost. 2021 Jun;19(6):1515-1518
pubmed: 33783953
Int J Hematol. 2022 Mar;115(3):424-427
pubmed: 34687421
Cureus. 2022 Jul 6;14(7):e26602
pubmed: 35936148
Front Med (Lausanne). 2021 Sep 30;8:751598
pubmed: 34660652
Clin Immunol. 2021 May;226:108721
pubmed: 33823270
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):172-180
pubmed: 34661927
Vaccine. 2021 Jun 8;39(25):3329-3332
pubmed: 34006408
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e626-e627
pubmed: 34077572
Blood Adv. 2021 Dec 28;5(24):5468-5478
pubmed: 34592758
Cureus. 2021 Oct 23;13(10):e18985
pubmed: 34820240